Associate Principal Scientist, Protein Engineering Machine Learning, Discovery Biologics

We are seeking an experienced and passionate Associate Principal Scientist to join the Protein Engineering Machine Learning and Discovery Biologics team at Merck & Co. As a key member of this team, the Associate Principal Scientist will leverage their expertise in machine learning and protein engineering to develop new strategies for biologics discovery.The ideal candidate will have an advanced degree in a relevant field such as biochemistry, molecular biology, bioengineering, or biotechnology; a minimum of 8 years of experience in protein engineering, molecular biology, and/or biotechnology; experience in developing machine learning algorithms and applying them to biologics discovery; and a successful track record of leading high-performance teams in a fast-paced environment.The Associate Principal Scientist will join a team of highly talented and motivated professionals who are passionate about developing the next generation of biologics. If you have the expertise and desire to join us in this exciting journey, we would love to hear from you!

According to JobzMall, the average salary range for a Associate Principal Scientist, Protein Engineering Machine Learning, Discovery Biologics in Boston, MA, USA is between $115,000 and $160,000 per year. This salary range is based on a variety of factors including experience, location, and market trends.

Merck & Co., Inc., d.b.a. Merck Sharp & Dohme outside the United States and Canada, is an American multinational pharmaceutical company and one of the largest pharmaceutical companies in the world. Merck & Co., Inc. engages in the provision of health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products. It operates through the following segments: Pharmaceutical, Animal Health, Alliances and Healthcare Services. The Pharmaceutical segment includes human health pharmaceutical and vaccine products marketed either directly by the company or through joint ventures.